Denis Bugnon

1.3k total citations
32 papers, 816 citations indexed

About

Denis Bugnon is a scholar working on Pharmacology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Denis Bugnon has authored 32 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 18 papers in Infectious Diseases and 16 papers in Molecular Medicine. Recurrent topics in Denis Bugnon's work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Antibiotic Resistance in Bacteria (16 papers) and Antimicrobial Resistance in Staphylococcus (14 papers). Denis Bugnon is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (25 papers), Antibiotic Resistance in Bacteria (16 papers) and Antimicrobial Resistance in Staphylococcus (14 papers). Denis Bugnon collaborates with scholars based in France and Switzerland. Denis Bugnon's co-authors include G. Potel, J. Caillon, Cédric Jacqueline, F Tasseau, M. Pinaud, V. Le Mabecque, P Desjars, A.-F. Miegeville, Marie-France Kerguéris and Éric Batard and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Critical Care Medicine and European Respiratory Journal.

In The Last Decade

Denis Bugnon

30 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denis Bugnon France 16 395 351 290 228 179 32 816
M L van Ogtrop Netherlands 14 381 1.0× 274 0.8× 341 1.2× 335 1.5× 162 0.9× 20 981
Lala M. Dunbar United States 16 258 0.7× 465 1.3× 396 1.4× 176 0.8× 254 1.4× 22 1.1k
Harald H. Reinhart United States 17 267 0.7× 325 0.9× 185 0.6× 263 1.2× 89 0.5× 26 880
Thomas R. Beam United States 17 247 0.6× 401 1.1× 167 0.6× 166 0.7× 120 0.7× 45 869
C H Nightingale United States 17 657 1.7× 427 1.2× 192 0.7× 325 1.4× 115 0.6× 37 1.0k
Sumathi Nambiar United States 17 241 0.6× 241 0.7× 188 0.6× 181 0.8× 98 0.5× 37 911
A. Georgopoulos Austria 17 333 0.8× 243 0.7× 157 0.5× 125 0.5× 99 0.6× 48 883
Jan G. den Hollander Netherlands 16 477 1.2× 473 1.3× 289 1.0× 371 1.6× 80 0.4× 32 1.2k
Pamela R. Tessier United States 19 675 1.7× 648 1.8× 290 1.0× 511 2.2× 114 0.6× 41 1.1k
Heino Staß Germany 21 614 1.6× 424 1.2× 171 0.6× 280 1.2× 114 0.6× 54 1.2k

Countries citing papers authored by Denis Bugnon

Since Specialization
Citations

This map shows the geographic impact of Denis Bugnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Bugnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Bugnon more than expected).

Fields of papers citing papers by Denis Bugnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Bugnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Bugnon. The network helps show where Denis Bugnon may publish in the future.

Co-authorship network of co-authors of Denis Bugnon

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Bugnon. A scholar is included among the top collaborators of Denis Bugnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Bugnon. Denis Bugnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caillon, J., et al.. (2012). The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model. European Journal of Clinical Microbiology & Infectious Diseases. 31(10). 2545–2547. 10 indexed citations
2.
Giannoni, Éric, Paul Majcherczyk, René Chiolero, et al.. (2010). Prospective monitoring of cefepime in intensive care unit adult patients. Critical Care. 14(2). R51–R51. 85 indexed citations
3.
Guen, Christèle Gras‐Le, J. Caillon, Denis Bugnon, et al.. (2008). Effet de la fixation protéique et de la demi-vie sérique d'élimination sur l'activité in vivo du céfotaxime et de la ceftriaxone dans un modèle d'endocardite à Escherichia coli chez le lapin. 3(3). 163–168.
4.
5.
Guen, Christèle Gras‐Le, Anne Jarry, G. Vallette, et al.. (2005). Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung. European Respiratory Journal. 25(1). 88–95. 5 indexed citations
6.
Batard, Éric, Marie Emmanuelle Juvin, Cédric Jacqueline, et al.. (2004). Influence of Carbon Dioxide on the MIC of Telithromycin for Streptococcus pneumoniae : an In Vitro - In Vivo Study. Antimicrobial Agents and Chemotherapy. 49(1). 464–466. 3 indexed citations
7.
Jacqueline, Cédric, Dominique Navas, Éric Batard, et al.. (2004). In Vitro and In Vivo Synergistic Activities of Linezolid Combined with Subinhibitory Concentrations of Imipenem against Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 49(1). 45–51. 77 indexed citations
8.
Dubé, Laurent, J. Caillon, Christèle Gras‐Le Guen, et al.. (2003). Simulation of Human Gentamicin Pharmacokinetics in an Experimental Enterococcus faecalis Endocarditis Model. Antimicrobial Agents and Chemotherapy. 47(11). 3663–3666. 7 indexed citations
9.
Guen, Christèle Gras‐Le, Thierry Debillon, Claire Toquet, et al.. (2003). Persistent Bacteremia in Rabbit Fetuses despite Maternal Antibiotic Therapy in a Novel Intrauterine-Infection Model. Antimicrobial Agents and Chemotherapy. 47(7). 2125–2130. 6 indexed citations
10.
Asseray, Nathalie, J. Caillon, Cédric Jacqueline, et al.. (2002). Different Aminoglycoside-Resistant Phenotypes in a Rabbit Staphylococcus aureus Endocarditis Infection Model. Antimicrobial Agents and Chemotherapy. 46(5). 1591–1593. 15 indexed citations
11.
Jacqueline, Cédric, V. Le Mabecque, O. Patey, et al.. (2002). Activité de l’amoxicilline in vivo dans l’endocardite expérimentale du lapin à Corynebacterium diphtheriae non toxinogène. Pathologie Biologie. 50(9). 513–515. 2 indexed citations
12.
Jacqueline, Cédric, Éric Batard, David Boutoille, et al.. (2002). In Vivo Efficacy of Continuous Infusion versus Intermittent Dosing of Linezolid Compared to Vancomycin in a Methicillin-Resistant Staphylococcus aureus Rabbit Endocarditis Model. Antimicrobial Agents and Chemotherapy. 46(12). 3706–3711. 59 indexed citations
13.
Bugnon, Denis, G. Potel, Yan Q. Xiong, et al.. (1997). Bactericidal effect of pefloxacin and fosfomycin againstPseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo. European Journal of Clinical Microbiology & Infectious Diseases. 16(8). 575–580. 5 indexed citations
14.
Bugnon, Denis, G. Potel, J. Caillon, et al.. (1996). In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model. Antimicrobial Agents and Chemotherapy. 40(5). 1164–1169. 18 indexed citations
15.
Xiong, Yan-Qiong, J. Caillon, G. Potel, et al.. (1995). Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or both. Journal of Antimicrobial Chemotherapy. 35(5). 697–706. 9 indexed citations
16.
Juvin, Marie Emmanuelle, G. Potel, J. Caillon, et al.. (1994). In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis. Antimicrobial Agents and Chemotherapy. 38(4). 883–885. 4 indexed citations
17.
Conte, Philippe Le, G. Potel, P Peltier, et al.. (1993). Lung Distribution and Pharmacokinetics of Aerosolized Tobramycin. American Review of Respiratory Disease. 147(5). 1279–1282. 73 indexed citations
18.
Potel, G., J. Caillon, Florence Le Gallou, et al.. (1992). Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis. Antimicrobial Agents and Chemotherapy. 36(4). 744–750. 16 indexed citations
19.
Desjars, P, M. Pinaud, Denis Bugnon, & F Tasseau. (1989). Norepinephrine therapy has no deleterious renal effects in human septic shock. Critical Care Medicine. 17(5). 426–429. 109 indexed citations
20.
Potel, G., et al.. (1988). [Experimental Enterobacter cloacae endocarditis treated with gentamicin. Predictive value of the in vitro bactericidal rate].. PubMed. 36(5). 536–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M L van Ogtrop Breakdown of academic impact, for papers by Lala M. Dunbar Breakdown of academic impact, for papers by Harald H. Reinhart Breakdown of academic impact, for papers by Thomas R. Beam Breakdown of academic impact, for papers by C H Nightingale Breakdown of academic impact, for papers by Sumathi Nambiar Breakdown of academic impact, for papers by A. Georgopoulos Breakdown of academic impact, for papers by Jan G. den Hollander Breakdown of academic impact, for papers by Pamela R. Tessier Breakdown of academic impact, for papers by Heino Staß
Rankless by CCL
2026